In the U.S., MONJUVI® (tafasitamab-cxix) is approved by the U.S. Food and Drug Administration in combination with lenalidomide and rituximab for the treatment of adult patients with relapsed or ...

The Food and Drug Administration (FDA) formally requested for a popular kratom derivative to be classified as a ...

A new radioimmunotherapy approach has been shown to successfully eliminate cancer stem cells (CSCs) in preclinical models of ...

Norgine, announced today the inclusion of IFINWIL® (eflornithine) on Australia's Pharmaceutical Benefits Scheme (PBS). This ...

China's top leaders have pledged to help companies slammed by higher U.S. tariffs but held back on major moves after trade ...

The Milwaukee Brewers got some rough news on Monday. Milwaukee reliever Rob Zastryzny has been working his way back from a rib injury but re-aggrevated it, per ...

Researchers in China have developed a powerful machine learning model that can help determine which patients with nasopharyngeal carcinoma (NPC) are likely to respond well to radiotherapy-a common ...

DelveInsight's Triple-Negative Breast Cancer Market Insights report includes a comprehensive understanding of current ...

Check the 2025 album release calendar to see what new rock and metal albums just came out.

The triple-negative breast cancer market is expected to grow due to rising incidence rates, increasing awareness, advancements in targeted therapies, ongoing clinical trials, improved diagnostics ...